Nephro Care India Ltd.

NSE: NEPHROCARE

Nephro Care Live Share Price Today, Share Analysis and Chart

Name: Nephro Care India Ltd.: Is Infosys Ltd. worth buying?
Item: Nephro Care India Ltd.
Rating: 2.254916625
Author: Trendlyne DVM scores

Mid-range Performer

aboutNephro Care India Ltd. is a specialized healthcare provider focused on comprehensive kidney care. Based in Kolkata, West Bengal, the company addresses the significant demand-supply gap in renal healthcare services in Eastern India. It provides a rang... Read More

-0.80(-0.98%)

48.51% Fall from 52W High

2,000

NSE Volume

NSE 02 Nov, 2026 2:05 PM (IST)

Portfolio

Alert

My Notes

Durability score

- / 100

Valuation Score

- / 100

Momentum Score

45.6 / 100

Mid-range PerformerThese stocks have average quality, financial and technical momentum, indicating a mid range performerView Similar Embed DVM

Analyst Price Target

No estimates available

SWOT Analysis

Check Before You Buy

VIEW FULL CHECKLIST

Medium rank

9Positive10Negative

47.4%Pass in checklist

045

100

Check P/E Buy Sell Zone

Buy Zone

27.0 % into P/E buy sell zone

% time spent below current P/E

020406080100

Strong upside potential

Gains already realized

Nephro Care Stock Price Analysis

Day Price Range -1.0% 1 Day return	80.5 (LTP) 8083.9 LowHigh
Week Price Range -3.0% 1 Week return	80.5 (LTP) 7885 LowHigh
Month Price Range -10.2% 1 Month return	80.5 (LTP) 7892 LowHigh
52 Week Price Range -40.9% 1 Year return	80.5 (LTP) 50156.4 LowHigh

View full Price History/Seasonality

Competitors/Peers

Revenue Mix

Quarterly

Annual

Balance Sheet

Ratios

Cash Flow

Documents

Nephro Care annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Nephro Care Mar-2026 Annual Revenue is Rs 90 Cr which is growth of 89.8% YoY.
NEGATIVE
Annual Net Profit Nephro Care Mar-2026 Annual Net Profit is Rs 3 Cr which is growth of -7.4% YoY.

Nephro Care India Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	TTM	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21
SR_A Total Rev. Ann. ⌄	74.1%	118.8%	102.3	90.3	47.6	27.6	17.1	3.4	1.8
TotalOperatingRevenues_A Operating Rev. Ann.	73.1%	118%	100.6	88.7	46	27.2	17.1	3.4	1.8
OI_A Other Income Ann.	-	-	1.7	1.6	1.5	0.4			0
OEXPNS_A Operating Exp. Ann.	81.3%	116.3%	89.2	80.4	40.2	20.8	13.5	3.3	1.7
OEXPNS_A Operating Exp. Ann.	81.3%	116.3%	89.2	80.4	40.2	20.8	13.5	3.3	1.7
OP_A Operating Profit Ann.	30.9%	110.7%	11.4	8.3	5.9	6.5	3.7	0.1	0.2
OPMPCT_A OPM Ann. %	-24.4%	1.8%		9.22%	12.35%	23.43%	21.32%	3.67%	8.44%
TotalExpenses_A Total Exp. Ann. ⌄	81.1%	119%		85.6	42.7	21.4	14.4	3.4	1.7
OtherExpenses_A Other Exp. Ann.	74.3%	165%	43.3	39.2	19.5	9.5	7.4	1.5	0.3
EmployeeBenefitExpenses_A Employee Exp. Ann.	137.8%	136.5%	15.7	14.8	7.6	2.2	1.1	0.3	0.2
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-	-
CostOfFuel_A Cost Of Fuel Ann.	-	-
EBIDT_A EBITDA Ann.	38.8%	118.2%		9.9	7.4	6.8	3.7	0.1	0.2
EBIDTPCT_A EBITDA Ann. margin %	-20%	4.3%		10.93%	15.56%	24.77%	21.34%	3.74%	8.86%
INT_A Interest Ann.	0%	-	0.1	0.2	0.1	0.1	0.2	0	0
DEP_A Depr.	85.4%	-	5.1	5.1	2.5	0.5	0.8	0.1	0
PBT_A PBT Ann.	19.4%	115.1%	7.9	4.6	4.8	6.2	2.7		0.1
TAX_A Tax Ann.	17.6%	-	2.3	1.3	1.2	1.7	0.8	0	0
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	21.4%	102.4%		3.4	3.6	4.5	1.9	-0	0.1
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-		-	-	-	-	-	-
NP_A Net Profit Ann.	21.4%	102.4%	5.6	3.4	3.6	4.4	1.9	-0	0.1
NETPCT_A NPM Ann. %	-30.6%	-4.9%		3.79%	7.90%	16.20%	11.36%	-0.28%	4.86%
EPS_adj_A EPS Adj. latest Ann.	18.6%	82.1%		2	2.2	2.7	1.2	-0	0.1

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

VIEW ALL TABLE IN FINANCIAL PAGE

Total Rev. Ann.

1Y CHG

89.7%

2Y CAGR

80.9%

3Y CAGR

74.1%

5Y CAGR

118.8%

Total Revenue Annual growth is stable compared to historical averages.

Net Profit Ann.

1Y CHG

-5.6%

2Y CAGR

-12.1%

3Y CAGR

21.4%

5Y CAGR

102.4%

Net Profit Annual is falling faster than historical averages.

Operating Exp. Ann.

1Y CHG

100%

2Y CAGR

96.6%

3Y CAGR

81.3%

5Y CAGR

116.3%

Operating Expenses Annual Cr growth is stable compared to historical averages.

Nephro Care Technical Analysis

Nephro Care EMA & SMA

Bearish-8

0 bullish, 8 bearish

Bullish0

Bearish8

5 Day	81.0
10 Day	82.2
12 Day	82.7
20 Day	84.2

26 Day	85.0
50 Day	85.2
100 Day	84.0
200 Day	90.6

Nephro Care Delivery And Volume

Daily Avg. Delivery Volume %

30 Oct, 202683.9%

Week73.9%

Month74.0%

Nephro Care Active Candlesticks

Belt Hold Uptrend Inside Uptrend Long Line Uptrend

Legend

Positive IndicatorNeutral IndicatorNegative Indicator

Nephro Care Resistance and Support

80.73

Pivot

First Resistance	82.6
Second Resistance	83.8
Third Resistance	85.7

First Support	79.5
Second Support	77.6
Third Support	76.4

Day RSI	41.9
Day MACD	-2.3
Day MFI	31.2
Day MACD Signal Line	-1.8

Nephro Care Beta

1 Month	0.7
1 Year	1.3

3 Month	0.8
3 Year	-

Nephro Care Price Change Analysis

↓-10.2%

Over 1 Month

LowHigh

7892

↑25.3%

Over 3 Months

LowHigh

62107.7

↑0.9%

Over 6 Months

LowHigh

60107.7

↓-40.9%

Over 1 Year

LowHigh

50.1156.4

Nephro Care Shareholding Pattern/ Ownership

Shareholding Summary

Sep 2026

Name	Category	Shares	Shares %
Pratim Sengupta	Promoter	10,054,000	61.0 %
Rohan Vinay Pai	Public	336,000	2.0 %

HISTORICAL PROMOTER HOLDING

Promoters holding remains unchanged at 61.71% in Sep 2026 qtr

HISTORICAL FII HOLDING

FII/FPI have decreased holdings from 0.96% to 0.73% in Sep 2026 qtr

HISTORICAL MF HOLDING

All Shareholding details

Nephro Care Deals - Insider, Bulk, Block and SAST

Client Name	Deal Type	Action	Date	Avg. Price	Quantity	Exchange
KAMAL KUMAR DUGAR & CO (PROP) KAMAL KUM	Bulk	Purchase	22 Aug 2025	171.32	83,200	NSE
TOPGAIN FINANCE PRIVATE LIMITED	Bulk	Sell	07 Aug 2024	281.67	86,400	NSE
MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED	Bulk	Sell	07 Aug 2024	271.63	171,200	NSE
SAHASTRAA ADVISORS PRIVATE LIMITED	Bulk	Sell	07 Aug 2024	278.26	200,000	NSE
TOPGAIN FINANCE PRIVATE LIMITED	Bulk	Purchase	07 Aug 2024	275.19	99,200	NSE
SAHASTRAA ADVISORS PRIVATE LIMITED	Bulk	Purchase	07 Aug 2024	276.60	224,000	NSE
AEGIS INVESTMENT FUND PCC	Bulk	Purchase	07 Aug 2024	287.85	131,200	NSE
MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED	Bulk	Purchase	07 Aug 2024	271.50	97,600	NSE
MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED	Bulk	Sell	06 Aug 2024	285.76	32,000	NSE
MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED	Bulk	Purchase	06 Aug 2024	285.82	88,000	NSE

All deals

All insider trades

Nephro Care Corporate Actions

Nephro Care Board Meetings

Nephro Care past and upcoming board meetings.

#Ex-Date	Purpose	Notes
107 Aug 2026	Others	To consider other business matters
227 May 2026	Audited Results & Others	To consider other business matters.
313 Feb 2026	Quarterly Results & Others	To consider other business matters.
412 Nov 2025	Quarterly Results & Others	To consider other business matters.
510 Jul 2025	Others	To consider other business matters.

All Corporate Actions

Nephro Care Research Reports

Nephro Care research reports with share price targets, and buy/hold/sell recommendations from top brokers.

# Date	Broker Name	Target	Price When Recommended	Type	Upside	Change Since Recommendation	Links
109 Dec 2025	HDFC Securities	-	121.25	IPO Note	-	-33.61%	pdf
208 Dec 2025	Ventura	-	121.25	IPO Subscribe	-	-33.61%	pdf

All Reports of Nephro

Nephro Care - Company Profile

Nephro Care Management Structure

Nephro Care management structure with salaries, total experience, and qualifications.

NAME	DESIGNATION	GROSS REMUNERATION ₹(LAC)	AS OF
Mr. Tapas Saha	Chief Financial Officer	-	Mar 26
SOUGATA SENGUPTA	Company Secretary,Compliance Officer	-	Mar 26
Mr. Arnab Majumder	Chief Operating Officer	-	Mar 26
Pratim Sengupta	Chairman.,Executive Director,Managing Director,Chief Executive Officer	-	Mar 26

Nephro Care Board of Directors

Nephro Care Board of directors with salaries, total experience, and qualifications.

NAME	POSITION	GROSS REMUNERATION ₹(LAC)	AS OF
Pratim Sengupta	Chairman & Managing Director	-	Mar 25
Pritam Sengupta	Non-Exec & Non-Independent Dir	-	Mar 25
Alo Sengupta	Independent Non Exe. Director	-	Mar 25
SAIKAT BISWAS	Independent Non Exe. Director	-	Mar 25
SUDIP BARMAN	Independent Non Exe. Director	-	Mar 25
Sutapa Sen	Non-Exec & Non-Independent Dir	-	Mar 25
Sandeep Shridhar Ghate	Independent Non Exe. Director	-	Mar 25
Debashsh Ghoshal	Non Executive Director	-	Mar 25
SOUGATA SENGUPTA	Company Sec. & Compli. Officer	-	Mar 25

About

Website: www.nephrocareindia.com

About the company - Business Profile

Nephro Care India Ltd. is a specialized healthcare provider focused on comprehensive kidney care. Based in Kolkata, West Bengal, the company addresses the significant demand-supply gap in renal healthcare services in Eastern India. It provides a range of clinical and diagnostic services for patients suffering from various stages of chronic kidney disease (CKD), particularly focusing on dialysis treatments and transplant support.

Key Points

Key Facts: Founded in 2014, Nephro Care India Ltd. is headquartered in Kolkata, West Bengal. The company successfully completed its Initial Public Offering (IPO) in July 2024 and is listed on the NSE SME platform under the symbol NEPHROCARE.
Operations and Resources: As of FY2024-25, the company operates several dialysis centers and clinics across West Bengal. Its primary hub is located in Salt Lake, Kolkata. The company is currently executing a major expansion through the establishment of Vivacity, a 100-bed multi-specialty hospital in Madhyamgram, Kolkata, dedicated to renal and related specialties.
Business Model: The company operates on a hub-and-spoke model. It combines high-end tertiary care (hub) with community-based dialysis centers (spokes). Revenue is primarily generated through clinical services, dialysis treatments, pharmacy sales, and diagnostic tests.
Strategic Importance: Nephro Care serves a critical role in Eastern India, where the prevalence of diabetes and hypertension is high, leading to increased CKD incidence. The company aims to provide affordable and accessible renal care, reducing the travel burden for patients in semi-urban and rural areas.
Financial Performance (FY2023-24):
- Revenue from Operations: ₹27.75 Crore.
- EBITDA: ₹6.24 Crore.
- Profit After Tax (PAT): ₹4.39 Crore.
- Net Profit Margin: Approximately 15.8%.
Revenue Breakdown: The majority of revenue is derived from dialysis and clinical procedures (approx. 70%), followed by pharmacy sales (approx. 20%) and other ancillary diagnostic services (10%). Operations are currently localized to the Eastern Indian region, primarily West Bengal.
Key Initiatives and Outlook:
- IPO Proceeds: The company raised approximately ₹41 Crore through its IPO in 2024, with the primary objective of funding the Vivacity Multi-Specialty Hospital project.
- Expansion: Plans to expand its spoke clinic network to cover more districts in West Bengal and neighboring states in Northeast India.
- Technology: Integration of advanced hemodialysis machines and clinical management software to monitor patient outcomes in real-time.
Employee Count: The company employs over 150 healthcare professionals, including nephrologists, specialized dialysis technicians, and nursing staff.

References

Nephro Care FAQ

Nephro Care today is trading in the red, down by 0.98% at ₹80.5.

Nephro Care is currently trading down 0.98% on an intraday basis. In the past week the stock fell 3.01%. Stock has been up 25.29% in the past quarter and fell 40.94% in the past year. You can view this in the share price history/seasonality section.

Nephro Care is listed on NSE with the ticker NEPHROCARE. It's currently trading on NSE at a share price of ₹80.5.

The market cap of Nephro Care is ₹132.72 Cr. as of Nov 02, 2026.

Nephro Care has never announced any dividend since the time of its listing on the NSE exchange.

Nephro Care has never issued stock splits or bonus shares since the time of its listing on the NSE exchange.

Nephro Care reported ₹29.41 Cr. in revenue, ₹1.61 Cr. in net profit, and ₹3.84 Cr. in EBITD as of Aug 14, 2026 for Q1 FY26-27.

There are no analyst predictions for stock price target for Nephro Care.

The PE ratio of Nephro Care is 39.39 as of Nov 02, 2026.

The PB ratio of Nephro Care is 2.27 as of Nov 02, 2026.

You can view the latest analyst reports on the Nephro Care reports dashboard. Either click on the Reports tab on this page's sub-header or click here to be directed to the dashboard.

You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.

Key Metrics
DVM
Price Chart
Forecaster
Financials
Technicals
Shareholding
Deals
Documents
Corporate actions
Company Profile

Nephro Care Live Share Price Today, Share Analysis and Chart

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Nephro Care Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

Nephro Care - Annual

Nephro Care annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Annual Revenue Nephro Care Mar-2026 Annual Revenue is Rs 90 Cr which is growth of 89.8% YoY.

Annual Net Profit Nephro Care Mar-2026 Annual Net Profit is Rs 3 Cr which is growth of -7.4% YoY.

Nephro Care Technical Analysis

Nephro Care EMA & SMA

Nephro Care Delivery And Volume

Nephro Care Active Candlesticks

Nephro Care Resistance and Support

Nephro Care Beta

Nephro Care Price Change Analysis

Nephro Care Shareholding Pattern/ Ownership

Shareholding Summary

HISTORICAL PROMOTER HOLDING

HISTORICAL FII HOLDING

HISTORICAL MF HOLDING

Nephro Care Deals - Insider, Bulk, Block and SAST

Bulk Block Deals

Insider Trading & SAST

Nephro Care Corporate Actions

Nephro Care Board Meetings

Nephro Care past and upcoming board meetings.

Nephro Care Research Reports

Nephro Care research reports with share price targets, and buy/hold/sell recommendations from top brokers.

Nephro Care - Company Profile

Nephro Care Management Structure

Nephro Care management structure with salaries, total experience, and qualifications.

Nephro Care Board of Directors

Nephro Care Board of directors with salaries, total experience, and qualifications.

About the company - Business Profile

Key Points

References

Nephro Care FAQ

How is Nephro Care today?

Nephro Care today is trading in the red, down by 0.98% at ₹80.5.

How has Nephro Care performed historically?

Nephro Care is currently trading down 0.98% on an intraday basis. In the past week the stock fell 3.01%. Stock has been up 25.29% in the past quarter and fell 40.94% in the past year. You can view this in the share price history/seasonality section.

What is the current share price of Nephro Care on NSE and BSE exchanges?

Nephro Care is listed on NSE with the ticker NEPHROCARE. It's currently trading on NSE at a share price of ₹80.5.

What is the market cap of Nephro Care?

The market cap of Nephro Care is ₹132.72 Cr. as of Nov 02, 2026.

When did Nephro Care last pay a dividend, and what has its dividend history been?

Nephro Care has never announced any dividend since the time of its listing on the NSE exchange.

Has Nephro Care issued any bonus shares or share splits recently?

Nephro Care has never issued stock splits or bonus shares since the time of its listing on the NSE exchange.

What do the financial statements and annual reports of Nephro Care Indicate?

Nephro Care reported ₹29.41 Cr. in revenue, ₹1.61 Cr. in net profit, and ₹3.84 Cr. in EBITD as of Aug 14, 2026 for Q1 FY26-27.

What is the target share price of Nephro Care according to analyst predictions in FY26-27?

There are no analyst predictions for stock price target for Nephro Care.

What is the PE Ratio of Nephro Care?

The PE ratio of Nephro Care is 39.39 as of Nov 02, 2026.

What is the PB Ratio of Nephro Care?

The PB ratio of Nephro Care is 2.27 as of Nov 02, 2026.

Where can I check the latest Research Reports about Nephro Care?

You can view the latest analyst reports on the Nephro Care reports dashboard. Either click on the Reports tab on this page's sub-header or click here to be directed to the dashboard.

How can I be notified of real time alerts about Nephro Care stock?

You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.